Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

Atg5 can promote tumors when autophagy is deficient but suppresses them under normal conditions.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

The photolyase-based device significantly changed the size and heat of potential skin cancer areas in patients.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Radiation damages hair stem cells and changes keratin expression, with Krt5 as a potential marker for radiation effects.

Cardiomyocyte-derived media can inhibit lung cancer cell growth and movement.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Keeping radiation doses under 16 Gy may reduce permanent hair loss.

2-Methoxyestradiol causes cancer cell death by activating specific pathways, but androgens can block this effect.

Caffeine intake during pregnancy and lactation can cause skin lesions in mother rats and their babies, not linked to cortisol levels.

Low-penetration genes might help personalize colorectal cancer prevention.

Rapid virilization should be checked for possible ovarian or adrenal cancer.

Controlling cellular changes can enable safe rejuvenation without cancer risk.

Presurgical models can effectively and affordably screen cancer prevention agents.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

The Kras mutation changes normal cell signals, leading to disrupted tissue structure and potential cancer.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Alpha mangostin may protect certain breast cancer cells by activating the p53 pathway.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.